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Reiner Wiest
Universitätsklinik für Viszerale Chirurgie und Medizin, Inselspital, Bern, SwitzerlandIt is both an honour and a privilege to introduce Prof. Dr. Guada-
lupe Garcia-Tsao on the occasion of the 2014 EASL International
Recognition Award 2014. ‘‘Lupe’’ or ‘‘Lupita’’ as the large group
of friends and family call her is Professor of Medicine at the Yale
University School of Medicine, where she is Director of the
Clinical and Translational Core at the NIH-funded Yale Liver
Center and Program Director of the Hepatitis C Resource Center.
In addition, she is Chief of Digestive Disease Section at the
Veterans Administration (VA) – Connecticut Healthcare System,
West Haven, Connecticut. Lupe is a longstanding member of
EASL. Her record of service to the organization and to the ﬁeld
of Hepatology is extraordinary. The International Recognition
Award is a special honour, awarded for distinguishing features
as well as excellence of character and academic performance.
Lupe stands out in all of these parameters, thus making her a
natural choice for recognition by one of the highest EASL honours.
Lupe was born and grew up in Mexico City. Her mother was
Chinese and her father Mexican. He actually wanted her to pur-
sue a career in advertising (as he did) because a career in Medi-
cine was ‘‘not easy for a woman’’. However, already then she
did it ‘‘her way’’ and proceeded to Medical School in Mexico at
the renowned Universidad Nacional Autonoma de Mexico. During
her last year in medical school she became involved in liver
research with Dr. Marcos Rojkind. He and a young Dr. David Ker-
shenobich, who had just returned from a fellowship with Profes-
sor Sheila Sherlock, had started a placebo-controlled randomized
trial of colchicine for the treatment of cirrhosis. Lupe was highly
active in randomizing patients, supplying medications, collecting
data and, thereby, got hooked on to clinical research – a sustained
passion since then. The study was published in the New England
Journal of Medicine.
After graduating from medical school she competed for a
Internal Medicine residency slot at the Instituto Nacional de la
Nutricion, the premier and most coveted postgraduate medical
institution in Mexico with an acceptance rate in the single digits.
She was accepted and spent 3 years with a punishing schedule of
120 working hours per week and 4-month rotations. At that time
more than 80% of her colleagues were male. Lupe excelled in this
competitive environment because she did it ‘‘her way’’ without
having to ﬁght or complain, but solely based on her performance.
In her quest to pursue a career in clinical research and hepa-
tology, and following the steps of her mentors, she sought aJournal of Hepatology 20
E-mail address: reiner.wiest@insel.ch
Open access under CC BY-NC-ND license.fellowship position abroad. Among different possibilities, she
ﬁnally chose a position at the West Haven Veterans Administra-
tion (VA) and Yale University with Dr. Harold Conn. During these
3 years she established herself as a principal investigator despite
the fact that Harold Conn left for a one-year sabbatical shortly
after her arrival. She single-handedly completed the ﬁrst compar-
ative diagnostic study of spontaneous bacterial peritonitis. In fact,
this was the basis for her continued interest in other complica-
tions of cirrhosis such as ascites and hepatorenal syndrome.
Roberto Groszmann, then acting chief of the Liver Unit at the
VA, early on realized the academic potential of Lupe’s intellect,
personality and craving for research. Indeed, her pioneer-mentor
was extremely inﬂuential as a role model for Lupe’s future scien-
tiﬁc career. This serendipitous juncture did start a highly prosper-
ous partnership which has been ongoing for almost 30 years and14 vol. 61 j 472–474
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led to more than 30 publications that have changed the knowl-
edge and practice of cirrhosis and portal hypertension. Despite
having completed two clinical studies on pharmacological modu-
lation of portal pressure during her fellowship, she decided to
return to her alma mater in Mexico, the Instituto Nacional de la
Nutricion. She felt it to be her duty to pass on what she had
learned to young medical students, residents and fellows in Mex-
ico, in the same way she had been mentored. However, Roberto
Groszmann, foreseeing Lupe’s potential, enabled her to return
to Yale some years later. Struggling with the idea of leaving Mex-
ico, she accepted to return to Yale as an Assistant Professor of
Medicine in 1989 only on the premise of taking a ‘‘leave of
absence’’ rather than relinquishing her position in Mexico. This
was 25 years ago and she still is at Yale.
Clinical translational research with clear endpoints based on a
sharp sense of the pathophysiology of disease has always been
the focus and backbone of her scientiﬁc work. The area in which
Lupe has provided major contributions over the last 25 years is
the area of complications of cirrhosis. She was part of the
research team that established the threshold portal pressure level
for the development of varices and that performed the only pla-
cebo-controlled studies of non-selective beta-blockers in the pre-
vention of ﬁrst variceal haemorrhage and in the prevention of the
development of varices. Moreover, her studies on spontaneous
bacterial peritonitis helped establish diagnostic standards such
as inoculation of at least 10 ml of ascites into blood culture bot-
tles at the patient’s bedside and deﬁne cut-off levels of ascites
polymorphonuclear cell count to establish the diagnosis of spon-
taneous bacterial peritonitis. Her keen clinical observations and
thorough pathophysiological understanding allowed Lupe to
characterize the liver involvement in hereditary hemorrhagic tel-
angiectasia – a study that has been likewise been published in the
New England Journal of Medicine.
Most of these trials were supported by peer-reviewed funds
provided by the NIH or the VA Healthcare System, among them
a K-24 mentoring award from the NIH in 1999; several Merit
Review awards on studies on refractory ascites and a VA central
ofﬁce grant in 2001 to establish one of four Hepatitis C Resource
Centres across the country. This grant has been ongoing for more
than 10 years and has clearly helped to improve the care for vet-
erans with hepatitis C and associated complications, including, of
course, cirrhosis. It is important to note that it has become
extraordinarily challenging to receive funding for translational
human research with focus on pathophysiological aspects.
Despite this Lupe has insistently continued performing such
research. Knowledge derived from such ‘‘practical’’ issues has
helped deﬁne the natural history and course of cirrhosis and thus,
is fundamental to centre the focus of future research.
Lupe prides herself of being a consummate clinician and one
of her joys is to share clinical pearls with students, residents
and fellows, particularly those that link pathophysiology with a
clinical presentation and/or a given therapy. Many students and
residents have chosen a career in hepatology based on their inter-
actions with her in the wards or in the classroom.
A key personality trait is her enthusiasm that captivates her
audience when lecturing or rounding or discussing a project,
enthusiasm that infects anybody interacting with her. This
energy and determination are easily reﬂected in her name. ‘‘Gua-
dalupe’’ which in native American Aztecan (Nahuatl) languageJournal of Hepatology 201translates into ‘‘the one that crushes the serpent’s head’’. Moreover,
taking her nickname, Lupita, as an acronym:
L: for lively, vivacious and witty mind by which her students,
fellows, patients and colleagues get carried away.
U: for unstoppable or utterly honest and clear-cut transparent
communication whether related to scientiﬁc discussions, aca-
demic decisions or mentorship.
P: for powerful, forward-moving leader determined and
focused on key questions that are of practical daily relevance.
I: for intelligent and irrepressible, brilliant creative thinker
driven by immense curiosity.
T: for ‘‘tough as nails’’ when it comes to solving clinical prob-
lems for her patients or when taking on scientiﬁc challenges.
A: active, adventurous and amazing person and excellent
team worker being an asset in any endeavour that she is involved
in.
Finally no description of Lupe Garcia-Tsao could be complete
without mention of her love for cinema, rock-and-roll and cats.
Lupita’s personality and ‘‘her way of’’ knowing how to make
complex multifactorial clinical problems and entities appear easy
and logical makes her an outstanding lecturer. Thus, she is
invited frequently to speak at national and international meet-
ings. In fact, teaching is one of Lupe’s passions and has led to mul-
tiple named lectureships such as prominently the Telfer Reynolds
USC lectureship. She has received several prestigious awards such
as the Yale Humanism in Medicine Award and the Hugh Butt
award at the Mayo Clinic. She is an elected member of the Mex-
ican Academy of Sciences and is fellow of the Royal College of
Physicians.
Lupe has established long-standing professional and personal
relationships with others who would, like her, become prominent
physician-scientist members of the EASL, including Jaime Bosch
(former recipient of the ﬁrst EASL recognition award) and
Andrew Burroughs (former Secretary General of the EASL and last
year’s recipient of an EASL recognition award). Her inspiring
character and verve for mentoring junior researchers has likewise
drawn a number of individuals to perform research under her
direction, including Puneeta Tandon, Annalisa Berzigotti and Sal-
vador Augustin. While working in the laboratory of Roberto
Groszmann interaction with Cristina Ripoll and Alexander Zip-
prich got them hooked on to her spirit of research and they devel-
oped a scientiﬁc relationship that has led to various studies and
publications. In fact, the same has happened to me from the ﬁrst
day when I met Lupe after having arrived to Yale University as a
young postdoctoral Research Fellow in 1997. She introduced me
to the concept and importance of bacterial translocation which
like a seeding jab since then accompanies me. Not only this,
any further input from her or others boost this inoculation and
her continued mentorship resembles the archetype of academic
and scientiﬁc life for me.
Lupe was proud to become a member of the EASL in 1997
when she attended her ﬁrst EASL meeting precisely in London.
She has attended this meeting regularly since 2002. She served
as associate editor of the Journal of Hepatology and collaborated
closely with EASL leadership during her tenure as president-elect
and then as president of the AASLD in 2012. For Lupe, the presi-
dency of the AASLD represented a culminating event in her career
in that it allowed her to contribute to move forward the science
and practice of hepatology, focusing on mentoring and education.4 vol. 61 j 472–474 473
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EASL salutes Lupe Garcia-Tsao with one of its highest honours.
Lupe has made a clear difference in the lives of all of us that have
had the privilege to work with her. This includes but is not lim-
ited to ‘‘her way’’ of succeeding, mentoring, investigating, teach-
ing, taking care of patients and living. Since, modesty is her
middle name I know that the decoration provided by this award
goes beyond her expectations.474 Journal of Hepatology 201Acknowledgements
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